所属医院
- 港怡医院
- 香港浸信会医院
- 养和医院
- 圣德肋撒医院
- 圣保禄医院
- 仁安医院
Research
BA3011-002
A Phase 2 Study of BA3011 Alone and in Combination with Nivolumab in Adult Patients with Metastatic Non-Small Cell Lung Cancer Who Had Prior Disease Progression on a PD-1/L1, EGFR, or ALK Inhibitor
Diagnosis
Lung cancer
Principal Investigator
Open for recruitment
查看 Trial
BA3011-002
A Phase 2 Study of BA3011 Alone and in Combination with Nivolumab in Adult Patients with Metastatic Non-Small Cell Lung Cancer Who Had Prior Disease Progression on a PD-1/L1, EGFR, or ALK Inhibitor
Diagnosis
Lung cancer
Principal Investigator
Open for recruitment
查看 Trial
BA3011-002
A Phase 2 Study of BA3011 Alone and in Combination with Nivolumab in Adult Patients with Metastatic Non-Small Cell Lung Cancer Who Had Prior Disease Progression on a PD-1/L1, EGFR, or ALK Inhibitor
Diagnosis
Lung cancer
Principal Investigator
Open for recruitment
查看 Trial